Drug Shortage Report for MABCAMPATH
| Report ID | 207255 |
| Drug Identification Number | 02290960 |
| Brand name | MABCAMPATH |
| Common or Proper name | Alemtuzumab |
| Company Name | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALEMTUZUMAB |
| Strength(s) | 30MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 ml vial |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-18 |
| Estimated end date | 2023-12-25 |
| Actual end date | 2023-12-18 |
| Shortage status | Resolved |
| Updated date | 2023-12-19 |
| Company comments | Allocation has been initiated and may continue through 2023 to mitigate patient impact. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer service contact info: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2023-12-19 | English | Compare |
| v8 | 2023-12-18 | French | Compare |
| v7 | 2023-12-18 | English | Compare |
| v6 | 2023-10-19 | French | Compare |
| v5 | 2023-10-19 | English | Compare |
| v4 | 2023-10-18 | French | Compare |
| v3 | 2023-10-18 | English | Compare |
| v2 | 2023-10-18 | French | Compare |
| v1 | 2023-10-18 | English | Compare |
Showing 1 to 9 of 9